Anna V. Reisæter
Position:
Phone:
Email:
 

Author network for Anna V. Reisæter by COREMINE medical


Publications in press

Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Oyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV
Early Versus Late Acute Antibody-Mediated Rejection in Renal Transplant Recipients
Transplantation (in press)
PubMed 23632391

Publications 2013

Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T (2013)
Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
Diabetologia, 56 (6), 1364-71
PubMed 23549518

Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Group (2013)
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial
Clin Transplant, 27 (2), E151-6
PubMed 23351013

Publications 2012

Loftheim H, Midtvedt K, Hartmann A, Reisæter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A (2012)
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
Transplant Res, 1 (1), 9
PubMed 23369437

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2012)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 27 (1), 443-7
PubMed 21636826

Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
Am J Transplant, 12 (12), 3316-25
PubMed 22946930

Temme J, Kramer A, Jager KJ, Lange K, Peters F, Müller GA, Kramar R, Heaf JG, Finne P, Palsson R, Reisæter AV, Hoitsma AJ, Metcalfe W, Postorino M, Zurriaga O, Santos JP, Ravani P, Jarraya F, Verrina E, Dekker FW, Gross O (2012)
Outcomes of male patients with Alport syndrome undergoing renal replacement therapy
Clin J Am Soc Nephrol, 7 (12), 1969-76
PubMed 22997344

Vikse BE, Irgens LM, Karumanchi SA, Thadhani R, Reisæter AV, Skjærven R (2012)
Familial factors in the association between preeclampsia and later ESRD
Clin J Am Soc Nephrol, 7 (11), 1819-26
PubMed 22956264

Publications 2011

Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, Finne P, Hoitsma AJ, Pascual J, Jarraya F, Reisaeter AV, Collart F, Dekker FW, Jager KJ (2011)
Cardiovascular and noncardiovascular mortality among men and women starting dialysis
Clin J Am Soc Nephrol, 6 (7), 1722-30
PubMed 21734088

Reisaeter AV, Foss A, Hartmann A, Leivestad T, Midtvedt K (2011)
The kidney transplantation program in Norway since 2000
Clin Transpl, 111-8
PubMed 22755407

Publications 2010

Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2010)
Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrol Dial Transplant, 25 (4), 1289-93
PubMed 19934089

Publications 2009

Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Mørkrid L, Jenssen T, Hartmann A (2009)
Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
Clin Transplant, 23 (4), 511-8
PubMed 19210527

Reisaeter AV, Røislien J, Henriksen T, Irgens LM, Hartmann A (2009)
Pregnancy and birth after kidney donation: the Norwegian experience
Am J Transplant, 9 (4), 820-4
PubMed 18853953

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation
Transplantation, 88 (3), 429-34
PubMed 19667949

Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
Experience from an active preemptive kidney transplantation program--809 cases revisited
Transplantation, 88 (5), 672-7
PubMed 19741464

Publications 2008

Tangeraas T, Bjerre A, Lien B, Kyte A, Monn E, Cvancarova M, Leivestad T, Reisaeter AV (2008)
Long-term outcome of pediatric renal transplantation: the Norwegian experience in three eras 1970-2006
Pediatr Transplant, 12 (7), 762-8
PubMed 18208441

Publications 2007

Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007)
Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes
Transplantation, 83 (5), 600-6
PubMed 17353781

Publications 2006

Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A (2006)
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients
Transplantation, 82 (1), 62-8
PubMed 16861943

Bäckman L, Reisaeter AV, Wramner L, Ericzon BG, Salmela K, Brattström C (2006)
Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
Clin Transplant, 20 (3), 336-9
PubMed 16824151

Oien CM, Reisaeter AV, Os I, Jardine A, Fellström B, Holdaas H (2006)
Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study
Clin Transplant, 20 (3), 374-82
PubMed 16824157

Publications 2005

Øien CM, Reisaeter AV, Leivestad T, Pfeffer P, Fauchald P, Os I (2005)
Gender imbalance among donors in living kidney transplantation: the Norwegian experience
Nephrol Dial Transplant, 20 (4), 783-9
PubMed 15701672

Publications 2004

Sund S, Grimm P, Reisaeter AV, Hovig T (2004)
Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis
Nephrol Dial Transplant, 19 (11), 2838-45
PubMed 15385637

Sund S, Reisaeter AV, Scott H, Mollnes TE, Hovig T (2004)
Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies
Clin Nephrol, 62 (2), 121-30
PubMed 15356969

Publications 2003

Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal Ø, Mollnes TE (2003)
Complement activation in early protocol kidney graft biopsies after living-donor transplantation
Transplantation, 75 (8), 1204-13
PubMed 12717204

Publications 2002

Hartmann A, Jenssen T, Midtvedt K, Reisaeter AV, Fauchald P, Henriksen T, Monn E, Christophersen B (2002)
[Protein-creatinine ratio--a simple method for proteinuria assessment in clinical practice]
Tidsskr Nor Laegeforen, 122 (22), 2180-3
PubMed 12426892

Publications 2001

Reisaeter AV, Hartmann A (2001)
Risk factors and incidence of posttransplant diabetes mellitus
Transplant Proc, 33 (5A Suppl), 8S-18S
PubMed 11498199

Publications 1999

Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E (1999)
The role of HLA matching in renal transplantation: experience from one center
Rev Immunogenet, 1 (3), 343-50
PubMed 11256425

Reisaeter AV (1999)
[Kidney transplantation in Norway--a historical perspective]
Tidsskr Nor Laegeforen, 119 (21), 3163-6
PubMed 10522485

Sund S, Reisaeter AV, Fauchald P, Bentdal O, Hall KS, Hovig T (1999)
Living donor kidney transplants: a biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years
Nephrol Dial Transplant, 14 (10), 2445-54
PubMed 10528671

Publications 1998

Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E (1998)
A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients
Transplantation, 66 (4), 523-8
PubMed 9734498

Reisaeter AV, Thorsby E, Brinchmann JE (1998)
Allospecific helper T-lymphocyte repertoire in monozygotic twins
Scand J Immunol, 47 (4), 381-7
PubMed 9600321

Sund S, Reisaeter AV, Scott H, Fauchald P, Bentdal O, Sødal G, Hovig T (1998)
Morphological studies of baseline needle biopsies from living donor kidneys: light microscopic, immunohistochemical and ultrastructural findings
APMIS, 106 (11), 1017-34
PubMed 9890263

Publications 1997

Reisaeter AV, Leivestad T, Fauchald P, Brekke I, Thorsby E (1997)
Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients
Transplant Proc, 29 (7), 3099-100
PubMed 9365682

Publications 1996

Reisaeter AV, Brinchmann JE, Lundin KE, Thorsby E (1996)
Monozygotic twins display differences in their allospecific cytotoxic T-cell repertoire
Scand J Immunol, 44 (6), 638-42
PubMed 8972747

Reisaeter AV, Thorsby E, Brinchmann JE (1996)
Analysis of alloreactive helper T lymphocyte precursor frequencies. Influence of interleukin-2 produced by the stimulating cells
J Immunol Methods, 189 (1), 65-72
PubMed 8576581

Publications 1995

Reisaeter AV, Leivestad T, Albrechtsen D, Holdaas H, Hartmann A, Sødal G, Flatmark A, Fauchald P (1995)
Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients
Transplantation, 60 (3), 242-8
PubMed 7645036

Publications 1994

Hartmann A, Lund K, Holdaas H, Fauchald P, Reisaeter A, Berg KJ (1994)
Contrasting short-term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients
J Am Soc Nephrol, 5 (6), 1385-90
PubMed 7534496

Hartmann A, Reisaeter A, Holdaas H, Rolfsen B, Fauchald P (1994)
Accidental metabolic acidosis during hemodialysis
Artif Organs, 18 (3), 214-7
PubMed 8185487

Reisaeter AV, Fauchald P, Leivestad T, Holdaas H, Hartmann A, Pfeffer P, Sødal G (1994)
Plasma exchange in highly sensitized patients as induction therapy after renal transplantation
Transplant Proc, 26 (3), 1758
PubMed 8030121

Publications 1990

Dahl O, Horn A, Morild I, Halvorsen JF, Odland G, Reinertsen S, Reisaeter A, Kavli H, Thunold J (1990)
Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway
Cancer, 66 (11), 2286-94
PubMed 2245382